Skip to main content
. 2024 Sep-Oct;14(5):561–569. doi: 10.22038/AJP.2024.24342

Table 3.

Menstrual cycle status before the intervention

Menstrual before
Regular Irregular Total
group placebo Count 3 35 38
% within group 7.9% 92.1% 100.0%
intervention Count 1 37 38
% within group 2.6% 97.4% 100.0%
Total Count 4 72 76
% within group 5.3% 94.7% 100.0%
Menstrual after
group placebo Count 5 33 38
% within group 13.2% 86.8% 100.0%
intervention Count 16 22 38
% within group 42.1% 57.9% 100.0%
Total Count 21 55 76
% within group 27.6% 72.4% 100.0%

Group 1: placebo. Group 2: EPO 1000 mg/day. Chi-Square Tests. p value less than 5% was considered significant.